Tuberculosis during JAK inhibitor or TNF-α inhibitors therapy: a disproportionality analysis from WHO pharmacovigilance database.

tofacitinib - Generic mfg.

Jakafi (ruxolitinib) - Incyte

Rinvoq (upadacitinib) - AbbVie

Olumiant (baricitinib) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42716780

Antoine Parrot; Bénédicte Lebrun Vignes; Cendrine Godet; Jacques Cadranel; Kevin Bihan; Michel Djibré; Nicolas Veziris; Thomas Maitre

Sep 10, 2026